Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review

Warfarin has been an anticoagulant of choice in patients with advanced Chronic Kidney Diseases (CKD) at stages 4 and 5 for decades, but with the advent of Novel Oral Anticoagulants (NOACs), there has been a sharp rise in their prescriptions. Among all NOACS, apixaban is the least reliant on kidney f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Hameeda, Nwankwo, Ijeoma, Anam, Mahvish, Maharjan, Shrinkhala, Amjad, Zainab, Abaza, Abdelrahman, Vasavada, Advait M, Sadhu, Akhil, Valencia, Carla, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651588/
https://www.ncbi.nlm.nih.gov/pubmed/36381830
http://dx.doi.org/10.7759/cureus.30230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651588/
https://www.ncbi.nlm.nih.gov/pubmed/36381830
http://dx.doi.org/10.7759/cureus.30230

Ejemplares similares